Efficacy and specificity of chenodeoxycholic acid therapy for dissolving gallstones.
D001219:Aspartate Aminotransferases / Q000097:blood; D001647:Bile Acids and Salts / Q000627:therapeutic use*; D002635:Chenodeoxycholic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D002765:Cholecystography; D002769:Cholelithiasis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D002793:Cholic Acids / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004064:Digestive System / Q000187:drug effects; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects; D008111:Liver Function Tests; D008297:Male; D010919:Placebos; D012995:Solubility; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D001647:Bile Acids and Salts; D002793:Cholic Acids; D010919:Placebos; D014280:Triglycerides; D002635:Chenodeoxycholic Acid; D002784:Cholesterol; D001219:Aspartate Aminotransferases